Omid Hamid MD Chief, Translational Research/Immuno-Oncology Director, Experimental Therapeutics Cedars Sinai Foundation discusses the Multi-Modality Management of Melanoma in the Era of Immunotherapy
This presentation is a part of the MOASC Oncology Summit Annual Educational Symposium
This presentation was made possible by these companies:
Advertisement